What is the price-to-earnings ratio of PeptiDream?
The price-earnings ratio of PeptiDream is currently 17.39.
PeptiDream P/E 2024
PeptiDream P/E
17.39
Ticker
4587.T
ISIN
JP3836750004
WKN
A1W0KK
As of Nov 17, 2024, PeptiDream's P/E ratio was 17.39, a -82.31% change from the 98.28 P/E ratio recorded in the previous year.
The PeptiDream P/E history
PeptiDream Aktienanalyse
What does PeptiDream do?
PeptiDream Inc is a Japanese biotech company specializing in novel therapeutics and drugs. The company was founded in 2006 by Professor Hiroaki Suga, who established the field of peptide synthesis at the University of Tokyo. Peptides are short chains of amino acids used in pharmaceutical development and diagnosis. PeptiDream uses a patented technology to generate billions of different peptides, which can then be systematically tested for functionality and applicability. The company also utilizes artificial intelligence and machine learning to specifically find compounds that can potentially treat cancer or neurodegenerative diseases. PeptiDream has four diverse business areas focusing on different applications. The first area is the identification of new drugs, where the company collaborates with several pharmaceutical and biotech firms to develop new compounds. The second area focuses on the development of peptide-based diagnostics. An example of this is the PeelAVERT technology, which identifies cancer-causing proteins through a "peeling process" of skin samples. This allows for personalized cancer treatment and improves success rates. The third area involves the development of agrochemicals. PeptiDream aims to replace chemical pesticides with biodegradable peptide-based compounds that have no negative impact on the environment. The fourth area aims to enhance quality of life through the use of peptides. The company focuses on compounds that can strengthen the immune system or slow down the aging process. PeptiDream has made several groundbreaking discoveries, including the PD-1 inhibitor technology for cancer treatment. This method uses peptides to activate the body's immune system and kill cancer cells. PD-1 inhibitors have shown promising results in clinical studies for lung cancer, kidney cancer, and other tumor types. PeptiDream has also developed a technology called "Peptide Discovery Platform System 2.0," which allows for the rapid generation and analysis of billions of diverse peptides. This method has been patented and enables PeptiDream to quickly focus on the development of new compounds. PeptiDream is a global leader in the development of peptide therapeutics and diagnostics. The company has earned an excellent reputation and collaborates closely with various research institutions, pharmaceutical companies, and biotech firms. PeptiDream also invests in training the next generation of scientists and strives to provide the industry and society with new compounds. PeptiDream ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering PeptiDream's P/E Ratio
The Price to Earnings (P/E) Ratio of PeptiDream is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing PeptiDream's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of PeptiDream is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in PeptiDream’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about PeptiDream stock
How has the price-earnings ratio of PeptiDream changed compared to last year?
The price-to-earnings ratio of PeptiDream has increased by -82.31% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of PeptiDream high compared to other companies?
Yes, the price-to-earnings ratio of PeptiDream is high compared to other companies.
How does an increase in the price-earnings ratio of PeptiDream affect the company?
An increase in the price-earnings ratio of PeptiDream would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of PeptiDream affect the company?
A decrease in the price-earnings ratio of PeptiDream would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of PeptiDream?
Some factors that influence the price-earnings ratio of PeptiDream are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does PeptiDream pay?
Over the past 12 months, PeptiDream paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PeptiDream is expected to pay a dividend of 0 JPY.
What is the dividend yield of PeptiDream?
The current dividend yield of PeptiDream is .
When does PeptiDream pay dividends?
PeptiDream pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of PeptiDream?
PeptiDream paid dividends every year for the past 0 years.
What is the dividend of PeptiDream?
For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.
In which sector is PeptiDream located?
PeptiDream is assigned to the 'Health' sector.
Wann musste ich die Aktien von PeptiDream kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of PeptiDream from 11/17/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.
When did PeptiDream pay the last dividend?
The last dividend was paid out on 11/17/2024.
What was the dividend of PeptiDream in the year 2023?
In the year 2023, PeptiDream distributed 0 JPY as dividends.
In which currency does PeptiDream pay out the dividend?
The dividends of PeptiDream are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von PeptiDream
Our stock analysis for PeptiDream Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PeptiDream Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
